GlassScriptPhysician profile
Boyd C Hoddinott
NPI 1699765172
$340.10
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.24 · 2020: $120 · 2021: $170 · 2022: $24.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $70.32 | 2020-2021 | |
| Novo Nordisk INC | $51.41 | 2019-2022 | |
| Glaxosmithkline, LLC. | $42.40 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.36 | 2021 | |
| Lilly USA, LLC | $22.64 | 2019-2021 | |
| Eisai INC. | $17.49 | 2021 | |
| Merck Sharp & Dohme LLC | $15.94 | 2020 | |
| Abbvie INC. | $15.04 | 2021 | |
| Allergan, INC. | $14.42 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $13.73 | 2021 | |
| Amarin Pharma, INC. | $13.12 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.62 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.48 | 2021 | |
| Currax Pharmaceuticals LLC | $11.13 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boyd Hoddinott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.